Portal de Periódicos da CAPES

Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis

1983; Wiley; Volume: 26; Issue: 6 Linguagem: Inglês

10.1002/art.1780260618

1529-0131

Alan F. Ansher, John W. Melton, Anthony J. Sliwinski,

Eosinophilic Disorders and Syndromes

Arthritis & RheumatismVolume 26, Issue 6 p. 804-805 Brief ReportFree to Read Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis Alan F. Ansher MD, Alan F. Ansher MD Medical Resident Division of Rheumatic Diseases, Department of Internal Medicine, Georgetown University Hospital, Washington, DC.Search for more papers by this authorJohn W. Melton III MD, John W. Melton III MD Clinical Instructor in Medicine Division of Rheumatic Diseases, Department of Internal Medicine, Georgetown University Hospital, Washington, DC.Search for more papers by this authorAnthony J. Sliwinski MD, Corresponding Author Anthony J. Sliwinski MD Chief Division of Rheumatic Diseases, Department of Internal Medicine, Georgetown University Hospital, Washington, DC.Division of Rheumatic Diseases, Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007Search for more papers by this author Alan F. Ansher MD, Alan F. Ansher MD Medical Resident Division of Rheumatic Diseases, Department of Internal Medicine, Georgetown University Hospital, Washington, DC.Search for more papers by this authorJohn W. Melton III MD, John W. Melton III MD Clinical Instructor in Medicine Division of Rheumatic Diseases, Department of Internal Medicine, Georgetown University Hospital, Washington, DC.Search for more papers by this authorAnthony J. Sliwinski MD, Corresponding Author Anthony J. Sliwinski MD Chief Division of Rheumatic Diseases, Department of Internal Medicine, Georgetown University Hospital, Washington, DC.Division of Rheumatic Diseases, Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007Search for more papers by this author First published: June 1983 https://doi.org/10.1002/art.1780260618Citations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Marshall FF, Klinefelter HF: Late hemorrhagic cystitis following low-dose cyclophosphamide therapy. Urology 14: 573–575, 1979 2 Plotz PH, Klippel JH, Decker JL, Grauman D, Wolff B, Brown BC, Rutt G: Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann Intern Med 91: 221–223, 1979 3 Garvin DD, Ball TP Jr: Bladder malignancy in a patient receiving cyclophosphamide for benign disease. Urology 18: 80–81, 1981 4 Isomaki HA, Hakalinen T, Joutsenlahti U: Excess risk of lymphoma and myeloma in patients with rheumatoid arthritis. J Chronic Dis 31: 691–696, 1978 5 Black KA, Zilko PJ, Dawkins RL, Armstrong BK, Mastaglia GL: Cancer in connective tissue disease. Arthritis Rheum 25: 1130–1133, 1982 6 Fairchild WV, Spence CR, Solomon HD, Gangai MP: The incidence of bladder cancer after cyclophosphamide therapy. J Urol 122: 163, 1979 7 Cox PJ: Cyclophosphamide cystitis and bladder cancer: a hypothesis. Eur J Cancer Clin Oncol 15: 1071–1072, 1979 8 Wall RL, Clausen KP: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 193: 271–273, 1975 9 Scharf J, Nahir M, Eidelman S, Jacobs R, Levin D: Carcinoma of the bladder with azathioprine therapy. JAMA 237: 152, 1972 10 Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of high and low doses of cyclophosphamide in 82 patients with rheumatoid arthritis (abstract). Arthritis Rheum 15: 434, 1972 11 Lidsky MD, Sharp JT, Billings S: Double-blind study of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum 16: 148–153, 1973 Citing Literature Volume26, Issue6June 1983Pages 804-805 ReferencesRelatedInformation